CREASY, George,O' BRIEN JR., John M.,DEFRANCO, Emily A.,MUSE, Kenneth N.
申请号：
MEP26509
公开号：
ME00930B
申请日:
2008.02.05
申请国别(地区):
ME
年份:
2012
代理人:
摘要：
Disclosed is the use of a progesterone selected from natural progesterone, 17-alphahydroxyprogesterone caproate, medroxyprogesterone acetate, norethindrone, norethindrone acetate, norethindrone enanthate, desogestrel, levonorgestrel, lynestrenol, ethynodiol diacetate, norgestrel, norgestimate, norethynodrel, gestodene, drospirenone, trimegestone, levodesogestrel, gestodyne, nesterone and etonogestrel, in the manufacture of a medicament for treating or preventing the onset of preterm labour and subsequent preterm birth in a pregnant woman with a short cervix of from 1.0 to 3.5 cm, wherein the progesterone is used in an amount sufficient to minimize the shortening of the cervix.Postupak za lečenje ili prevencjju spontanog prevremenog porođaja kod trudnica i poboljšavanje neonatalnog morbiditeta i smrtnosti. Postupak obuhvata davanje trudnicama efikasne količine progesterna dovoljne da produži trudnoću minimiziranjem skraćivanja ili otvaranja njihovog grlića. Tretman i profilaksa progesteronom trudnica koje imaju simpotme kratkog grlića je klinički dokazano da povećava neonatalno zdravlje.
